Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Double-Blinded, Placebo-Controlled Study of the Effect of XmAb®5871 on Systemic Lupus Erythematosus Disease Activity

NCT02725515 is registered in ClinicalTrials.gov with Xencor, Inc. as lead sponsor.

NCT NCT02725515
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02725515 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Double-Blinded, Placebo-Controlled Study of the Effect of XmAb®5871 on Systemic Lupus Erythematosus Disease Activity
Lead sponsor
Xencor, Inc.
Phase
Phase 2
Overall status
Completed
Start date
February 16, 2016
Completion date
July 17, 2018
Enrollment
105 (actual)
Sites
23

Conditions

As the registry lists them; a condition with its own page is linked.

systemic lupus erythematosus